Stock VLA VALNEVA
Add to a list
To use this feature you must be a member
Log inSign up

News Valneva

Equities

VLA

FR0004056851

Market Closed - Euronext Paris
Other stock markets
 11:37:24 2024-05-10 am EDT 		5-day change 1st Jan Change
3.364 EUR +3.32% Intraday chart for Valneva -2.04% -28.73%
May. 07 Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024
Valneva: quarterly results boosted by PRV sale
CF
Valneva : Q1 2024 Financial Results
PU
Valneva : Reports First Quarter 2024 Financial Results and Provides Corporate Updates
PU
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GL
Valneva SE Confirms Earnings Guidance for the Fiscal Year 2024
CI
Valneva : Document AMF CP. 2024E960493
PU
Valneva: Deep Track Biotechnology Master holds less than 5% of the capital
CF
World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults
PU
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate
MT
Valneva: Phase 1 trial initiated in the Zika virus
CF
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
AQ
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
GL
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
CI
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
GL
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
AQ
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
AQ
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.
GL
ADRs End Higher; XTL Biopharmaceuticals Climbs 129%
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VLA Stock
  4. News Valneva
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW